Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Night-time Thiazide Diuretics for Kidney Stones
NCT02711670Completed
- Sponsor
- VA New York Harbor Healthcare System
- Start
- Feb 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of chlorthalidone and hydrochlorothiazide in nephrolithiasis, sponsored by VA New York Harbor Healthcare System. Primary endpoints: Change in excretion of urine calcium at 1 week and Change in supersaturation of urine calcium oxalate / phosphate at 1 week. Started Feb 2014; status: completed.
02
Drugs
chlorthalidonehydrochlorothiazide
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT02711670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02711670.